Medtronic plc stock gains attention as diabetes spin-off and robotic surgery clearance reshape its o

{
  "signal_id": "041cc790-aeab-7c06-4c5b-799be93753d9",
  "signal_type": "news",
  "signal_subtype": "has_earnings",
  "detected_at": "2026-09-19T09:34:27+00:00",
  "company": {
    "name": "Medtronic",
    "domain": "medtronic.com"
  },
  "data": {
    "url": "https://www.ad-hoc-news.de/boerse/news/corporate-news/medtronic-plc-stock-gains-attention-as-diabetes-spin-off-and-robotic/70130434",
    "title": "Medtronic plc stock gains attention as diabetes spin-off and robotic surgery clearance reshape its o - AD HOC NEWS",
    "excerpt": "Medtronic plc stock (ISIN IE00BTN1Y115) closed at USD 92.13 on the New York Stock Exchange on September 18, 2026, putting the company’s market value above USD 100 billion and leaving the shares roughly midway between the 52-week low of USD 73.31 and the high of USD 106.33 per recent price data. According to The Globe and Mail on September 18, 2026, Medtronic launched an exchange offer on September 14, 2026 for up to 225,361,295 newly issued shares of MiniMed Group Inc. common stock in return for outstanding Medtronic ordinary shares, a transaction designed to advance the planned separation of its diabetes-focused MiniMed business and reshape the group’s equity structure. The same report notes that Medtronic clarified a typographical error in the prospectus governing guaranteed delivery procedures shortly after the offer began, confirming that the guaranteed delivery period for tender documentation expires at 5:00 p.m. New York City time on the second New York Stock Exchange trading day after execution, an adjustment aimed at reducing operational risk and ensuring accurate instructions for shareholders participating in the exchange. In a related regulatory filing, StockTitan highlighted a Medtronic communication filed under SEC rule 425 on September 18, 2026 describing the offer to exchange up to an aggregate of 225,361,295 newly issued shares of common stock of MiniMed Group...",
    "summary": "Medtronic reported earnings of USD 1.45 per share in its most recent quarter, surpassing the Zacks Consensus Estimate of USD 1.39 per share.",
    "planning": false,
    "image_url": "https://mdb.ad-hoc-news.de/bild/bild-2703856_1920_1080.webp",
    "confidence": 0.9,
    "published_at": "2026-09-19T09:34:27Z",
    "article_sentence": "According to Zacks on September 9, 2026, Medtronic’s last reported quarter showed earnings of USD 1.45 per share versus the Zacks Consensus Estimate of USD 1.39 per share, representing a positive earnings surprise of 4.32 percent and demonstrating the company’s ability to deliver modest upside against expectations.",
    "related_company_name": "Zacks",
    "related_company_domain": "zacks.com"
  }
}

curl https://signals.autobound.ai/v1/signals/041cc790-aeab-7c06-4c5b-799be93753d9 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"medtronic.com","limit":20}'